| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 49 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | Dawes Karen A63 | Director | Sale+OE | 4,783 | $263.93 | $1,262,354.72 | -0.5% | -27.3% | -28.3% | |
| Nov 4, 2021 | Ryan Thomas F Jr66 | Director | Sale+OE | 2,285 | $295.87 | $676,070.00 | -8.2% | -26.3% | -37.1% | |
| Nov 2, 2021 | Dawes Karen A63 | Director | Sell | 2,400 | $303.94 | $729,466.65 | -0.4% | -34.5% | -43.3% | |
| Oct 29, 2021 | Barthelemy Nicolas67 | Director | Sale+OE | 1,645 | $288.20 | $474,085.40 | -32.3% | -39.0% | -37.4% | |
| Sep 14, 2021 | Dawes Karen A63 | Director | Sell | 274 | $294.26 | $80,628.12 | - | -12.2% | -22.9% | |
| Sep 9, 2021 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 25,000 | $294.75 | $7,368,649.85 | -3.1% | -9.7% | -20.7% | |
| Sep 1, 2021 | Dawes Karen A63 | Director | Sale+OE | 3,459 | $283.91 | $982,057.54 | -0.6% | +0.2% | -25.2% | |
| Sep 1, 2021 | Gebski Christine62 | See Remarks | Sell | 3,377 | $285.33 | $963,559.41 | -9.2% | +0.2% | -25.2% | |
| Aug 30, 2021 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 4,001 | $282.13 | $1,128,802.13 | -18.7% | +2.9% | -22.3% | |
| Aug 18, 2021 | Dawes Karen A63 | Director | Sell | 18,956 | $254.18 | $4,818,219.37 | -1.7% | +5.6% | -5.3% |